image

The best stocks to buy since 1993

Latest issue now available

Regenersis

February 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RGS
  • Price:
  • 294p
Regenersis has issued an in-line update, with further growth from its operations in the emerging markets and from advanced solutions, together delivering double digit sales and profit growth. A focus on larger, higher value contracts is beginning to pay off and a number of contracts have been won, which will kick off across a number of different geographies and product lines during the second half. Amongst these was a new contract to deploy the IFT set top box diagnostic technology for a cable TV operator in Western Europe, Regenersis' first IFT contract outside the UK. The real gravy, however, is US contracts (where we hear an initial contract has been signed with AT&T though a roll out remains to be done). Panmure forecasts eps of ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe